Plunkett Research Online: Aptose Biosciences Inc

APTOSE BIOSCIENCES INC (APTO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Lux.....



Aptose Biosciences Inc
Ticker: APTO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 647-479-9828
Fax: 905-234-2120
Address: 251 Consumers Road
Suite 1105
Toronto, ON M2J 4R3 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Cancer
Biotechnology
Oncology Therapeutics
Clinical Trials
Contacts Description
William Rice CEO/Chairman of the Board/Chief Accounting Officer/Director/President
Fletcher Payne CFO/Senior VP
See More
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company has two clinical-stage programs and a second program that is discovery-stage and partnered with another company. Lux.....See More See More

Auditor: KPMG LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Luxeptinib (CG-806)
APTO-253
APL-581
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: